RLS AND EVERGREEN THERAGNOSTICS LAUNCH PARTNERSHIP FOR SALE AND DISTRIBUTION OF NEUROENDOCRINE TUMOR DIAGNOSTIC OCTEVY™ (KIT FOR PREPARATION OF GA 68 DOTATOC INJECTION), PENDING FDA APPROVAL

Expands RLS Capabilities and Offerings across the US, Begins to Establish Commercial Footprint for Evergreen LAKE ZURICH, Ill. and SPRINGFIELD, N.J., May 18, 2023 /PRNewswire/ — Today, RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the US, and Evergreen…

Click here to view original post